Fenster schließen  |  Fenster drucken

-keine kauf oder verkaufsempfehlung - !!


Bin hier gerade zu 0,40 US$ rein





Homepage http://www.advancedlifesciences.com/


Mkt Cap: $ Mio 18,63
Outstanding: 45,99 Mio. Stk
Float: 43,09 Mio. Stk





Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of drugs in the areas of infection, cancer and respiratory disease. The Company’s lead product candidate, cethromycin, is a novel once-a-day antibiotic developed for the treatment of respiratory tract infections. The Company has three product candidates that are either in clinical development or approved to begin clinical development, as well as six additional candidates in preclinical development.


Company Factsheet: http://www.advancedlifesciences.com/download/ADLS_Company_Fa…


Press Room
Date Title
06/02/09 Advanced Life Sciences Announces Outcome of FDA's Anti-Infective Drugs Advisory Committee Review of Restanza(TM) (cethromycin)
05/29/09 Advanced Life Sciences Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Restanza(TM) (cethromycin)
05/12/09 Advanced Life Sciences Announces First Quarter 2009 Financial Results and Financial Outlook
 
aus der Diskussion: Advanced Life Sciences | ADLS
Autor (Datum des Eintrages): finanzmarc  (04.06.09 18:02:21)
Beitrag: 1 von 19 (ID:37321680)
Alle Angaben ohne Gewähr © wallstreetONLINE